Wave Life Sciences Ltd. (WVE)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 17, 2025

$10.99

P/E Ratio

N/A

Market Cap

$1.68B

Loading...
Description

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Metrics

Overview

  • HQSingapore, CE
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerWVE
  • Price$10.99-2.83%

Trading Information

  • Market cap$1.68B
  • Float77.10%
  • Average Daily Volume (1m)851,043
  • Average Daily Volume (3m)1,130,299
  • EPS-$1.11

Company

  • Revenue$53.61M
  • Rev growth (1yr)-115.60%
  • Net income-$61.78M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$61.76M
  • EV$811.12M
  • EV/Revenue15.13
  • P/EN/A
  • P/S27.18
  • P/B11.51
Documents